Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic.

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          People with substance user disorder (SUD) have frequent intersections with the health care system; however, engagement and retention in SUD care remain low, particularly for marginalized populations. Low-threshold treatment models that aim to eliminate barriers to care are one proposed intervention to increase access and equity in SUD treatment.

          Related collections

          Most cited references52

          • Record: found
          • Abstract: found
          • Article: not found

          Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.

          Opioid-dependent patients often use the emergency department (ED) for medical care.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Buprenorphine Treatment Divide by Race/Ethnicity and Payment

            This study reports the seeming disparity in access to buprenorphine prescriptions among racial/ethnic minorities and individuals with lower income.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs

              People who inject drugs (PWID) are at risk for infective endocarditis (IE). Hospitalization rates related to misuse of prescription opioids and heroin have increased in recent years, but there are no recent investigations into rates of hospitalizations from injection drug use-related IE (IDU-IE). Using the Health Care and Utilization Project National Inpatient Sample (HCUP-NIS) dataset, we found that the proportion of IE hospitalizations from IDU-IE increased from 7% to 12.1% between 2000 and 2013. Over this time period, we detected a significant increase in the percentages of IDU-IE hospitalizations among 15- to 34-year-olds (27.1%–42.0%; P < .001) and among whites (40.2%–68.9%; P < .001). Female gender was less common when examining all the IDU-IE (40.9%), but it was more common in the 15- to 34-year-old age group (53%). Our findings suggest that the demographics of inpatients hospitalized with IDU-IE are shifting to reflect younger PWID who are more likely to be white and female than previously reported. Future studies to investigate risk behaviors associated with IDU-IE and targeted harm reduction strategies are needed to avoid further increases in morbidity and mortality in this rapidly growing population of young PWID.
                Bookmark

                Author and article information

                Journal
                J Subst Abuse Treat
                Journal of substance abuse treatment
                Elsevier BV
                1873-6483
                0740-5472
                Oct 2022
                : 141
                Affiliations
                [1 ] Massachusetts General Hospital, Department of Medicine, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: Swakeman@partners.org.
                [2 ] Massachusetts General Hospital, Department of Medicine, Boston, MA, USA.
                [3 ] Massachusetts General Hospital, Department of Medicine, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
                [4 ] Harvard Medical School, Boston, MA, USA; Massachusetts General Hospital, Department of Psychiatry, Boston, MA, USA.
                [5 ] Massachusetts General Hospital, Department of Psychiatry, Boston, MA, USA.
                Article
                S0740-5472(22)00130-1
                10.1016/j.jsat.2022.108848
                35926256
                2c50468a-a61d-4930-a4d1-b974bc471a11
                History

                Stimulant use disorder,Alcohol use disorder,Racial disparities,Opioid use disorder,Naltrexone,Low threshold,Buprenorphine,Bridge clinic

                Comments

                Comment on this article